Company Filing History:

7 out of 12,157

Bayer Aktiengesellschaft

patents

7 out of 378

Bayer Pharma Aktiengesellschaft

patents

7 out of 443

The Broad Institute, Inc.

patents

4. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2024

Loading Chart...

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12152041 - Macrocyclic fluorine substituted indole derivatives (2024-11-26),

2. 11891404 - Substituted macrocyclic indole derivatives (2024-02-06),

3. 11478451 - Macrocyclic chlorine substituted indole derivatives (2022-10-25),

4. 11447504 - Macrocyclic chlorine substituted indole derivatives (2022-09-20),

5. 11440923 - Substituted macrocyclic indole derivatives (2022-09-13),

6. 11401278 - Macrocyclic indole derivatives (2022-08-02),

7. 11286263 - Macrocyclic fluorine substituted indole derivatives (2022-03-29),

8. 10981932 - Macrocyclic indole derivatives (2021-04-20),

9. 6942766 - Chlorine generator (2005-09-13),

10. 5779874 - Chlor alkali cells method and cell compression system (1998-07-14),

11. 5551468 - Fluidic density control for chlor alkali cells (1996-09-03),

Title: The Inventive World of Chris A Lemke

Introduction

Chris A Lemke, a prolific inventor hailing from Fresno, CA, has made significant contributions to the field of pharmaceuticals with a total of 9 patents under his belt. Lemke's innovative spirit and dedication to advancing medical science have led to groundbreaking discoveries in the treatment of hyperproliferative disorders.

Latest Patents

Among his latest patents is the development of macrocyclic chlorine substituted indole derivatives. These compounds, represented by the general formula (I), have shown promise in treating various diseases, particularly hyperproliferative disorders. Lemke's inventions not only encompass the compounds themselves but also include methods of preparation, intermediate compounds, and pharmaceutical compositions for effective disease management.

Career Highlights

With a rich professional background, Lemke has been associated with renowned companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His tenure at these esteemed organizations has provided him with the platform to translate his innovative ideas into tangible patents that have the potential to revolutionize the pharmaceutical industry.

Collaborations

Lemke's collaborative spirit is evident through his partnerships with industry experts such as Sarah Anna Liesa Johannes and Philipp Buchgraber. Together, they have synergized their skills and knowledge to drive forward the development of novel pharmaceutical compounds with the aim of improving patient outcomes and expanding treatment options.

Conclusion

In conclusion, Chris A Lemke stands as a trailblazing inventor whose remarkable patents and collaborations have reshaped the landscape of pharmaceutical research. His dedication to innovation and relentless pursuit of scientific excellence continue to inspire advancements in the field, offering hope for the improved treatment of complex diseases.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.